HealthcareServices

COVID-19 Saliva Screening Test Potential Market 2026–2030: Forecast, Innovation, and Competitive Trends

February 23, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the covid-19 saliva screening test potential market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the COVID-19 Saliva Screening Test Potential Market show for the 2026–2030 period?

The potential market size for covid-19 saliva screening tests has seen significant growth in recent years. This market is projected to expand from $4.28 billion in 2025 to $4.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. The expansion witnessed in the past can be attributed to issues like the discomfort of swab-based testing, the requirement for frequent screening, concerns regarding infection control, the need for scalable testing solutions, and the overarching public health emergency response.

The potential market size for covid-19 saliva screening tests is expected to demonstrate robust growth over the next few years. This market is projected to reach $6.46 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.4%. The expansion during this forecast period can be attributed to evolving pandemic preparedness strategies, the rise of decentralized diagnostics, wider implementation of workplace testing, the demand for cost-effective mass screening, and advancements in saliva-based technologies. Significant trends for the forecast timeframe include a shift towards non-invasive testing methods, the expansion of large-scale community screening, increasing acceptance of self-collection testing, deployment in high-traffic public locations, and integration with workplace safety programs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16026&type=smp

What Drivers Are Shaping The Development Of The COVID-19 Saliva Screening Test Potential Market?

Rising healthcare spending is anticipated to stimulate the future growth of the COVID-19 saliva screening test potential market. Healthcare expenditure refers to the total funds disbursed for goods and services related to healthcare, encompassing prescription drugs, hospital stays, doctor appointments, medical equipment, and public health campaigns. This expenditure is increasing due to various elements, including minimally invasive surgeries, state-of-the-art diagnostic tools, an upsurge in research and development for new medicines, increased utilization of healthcare facilities, and specialized pharmaceutical products. Enhanced healthcare expenditure can provide the necessary support and resources to fully capitalize on the capabilities of COVID-19 saliva screening tests, contributing to more effective pandemic management and superior public health outcomes. For instance, in December 2024, as reported by the U.S. Centers for Medicare & Medicaid Services (CMS), a US-based federal health agency, national health-care spending climbed by 7.5%, reaching US $4.9 trillion, compared to the preceding year. Therefore, the expansion of the COVID-19 saliva screening test potential market is being driven by the rise in healthcare expenditure.

Which Segments Are Contributing To The Growth Of The COVID-19 Saliva Screening Test Potential Market?

The covid-19 saliva screening test potential market covered in this report is segmented –

1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations

2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9

3) By Mode Of Testing: Centralized Testing, Decentralized Testing

Subsegments:

1) By Travel Stations: Airports, Train Stations, Bus Stations, Seaports

2) By Sports Arenas: Stadiums, Arenas, Event Halls

3) By Entertainment Venues: Theaters, Concert Halls, Amusement Parks, Nightclubs

4) By Corporate Campus Environments: Offices, Corporate Campuses, Business Parks

5) By Universities And Colleges: Higher Education Campuses, Research Institutions, Student Housing Areas

6) By Factories: Manufacturing Plants, Production Facilities, Industrial Sites

7) By Other Locations: Healthcare Facilities, Government Buildings, Public Transportation Hubs, Shopping Centers

What Trends Are Reshaping The Dynamics Of The COVID-19 Saliva Screening Test Potential Market?

Leading companies operating in the potential market for COVID-19 saliva screening tests are concentrating on developing innovative technologies, such as data-sharing platforms, to improve real-time communication and collaboration among healthcare providers, laboratories, and public health authorities. This endeavor ultimately aims to enhance the efficiency and accuracy of testing, tracking, and response efforts throughout the pandemic. Data-sharing platforms are digital systems that facilitate the secure exchange of information among various stakeholders, including healthcare providers, researchers, and organizations. They are designed to foster cooperation and provide access to information, thereby improving decision-making, efficiency, and outcomes across different sectors. For instance, in May 2024, Mount Sinai Health System, a US-based healthcare network, launched the Center for Healthcare Readiness. The Center’s primary focus is on refining strategies for public health emergency response, ensuring that healthcare systems can effectively manage large-scale crises such as pandemics or natural disasters. Its objective is to strengthen the capacity of the Mount Sinai Health System and to collaborate with local, regional, and federal partners in developing comprehensive preparedness plans.

Who Are The Top-Performing Companies In The COVID-19 Saliva Screening Test Potential Market In Recent Years?

Major companies operating in the covid-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report

Which Region Currently Holds The Largest Share Of The COVID-19 Saliva Screening Test Potential Market?

North America was the largest region in the COVID-19 saliva screening test potential market in 2025. The regions covered in the covid-19 saliva screening test potential market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized COVID-19 Saliva Screening Test Potential Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16026&type=smp

Browse Through More Reports Similar to the Global COVID-19 Saliva Screening Test Potential Market 2026, By The Business Research Company

Artificial Saliva Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-saliva-global-market-report

Covid 19 Antigen Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/covid-19-antigen-test-global-market-report

Covid 19 Rapid Test Kits Market 2026

https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795